Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lantus versus NPH insulin in children and adolescents with type 1 diabetes mellitus
2014-004640-35Phase 3
- Sponsor
- Sanofi
- Start
- Mar 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in diabetes mellitus type 1 (T1D) comparing Lantus once daily with NPH insulin (2 arms). Primary endpoint: Absolute change of glycosylated hemoglobin (HbA1c).
02
Drugs
insulin glargineinsulin isophane
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2014-004640-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004640-35.